Christian Blank
MD, PhD
Medical Oncologist and Group Leader
👥Biography 个人简介
Christian Blank led the practice-changing NADINA trial showing neoadjuvant ipilimumab plus nivolumab with response-directed adjuvant therapy improves event-free survival over standard adjuvant nivolumab in resectable stage III melanoma. His OpACIN and OpACIN-neo studies pioneered neoadjuvant combination IO. He established pathologic response as a decision tool for adjuvant de-escalation.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Christian Blank 的研究动态
Follow Christian Blank's research updates
留下邮箱，当我们发布与 Christian Blank（Netherlands Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment